Broncho-Munal in the Treatment of Acute Obstructive Bronchitis in Children Who Are Often Sick

Obstructive bronchitis is one of the most frequent hospitalizations of young children, which is characterized by manifestations of broncho-obstructive syndrome, respiratory failure. The main causative agent of obstructive bronchitis is a virus. Since the main pathogenetic link is the formation of inflammation of the bronchi, we treated with the use of an immunostimulating drug - Bronxo-mynal. We have treated 40 patients aged 1 to 8 years who were divided into 2 groups. Patients received inpatient treatment at the Samarkand Branch of the Republican Scientific Center for Emergency Medical Care, in departments 1 and 2 of pediatrics. Group 2 was prescribed Bronxo-mynal, which was administered intramuscularly at a dose of 3.5 mg, 1 time every other day.